PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Sorena Kiani, MBPhD, FRCP, FRCPath - Androgen Risk Reduction in Hereditary Angioedema: Why and How to Switch to Targeted Prophylactic Therapy?
Visit https://www.peervoice.com/PBJ860 to view the entire programme with slides. After completing “Sorena Kiani, MBPhD, FRCP, FRCPath - Androgen Risk Reduction in Hereditary Angioedema: Why and How to Switch to Targeted Prophylactic Therapy?”, participants will be able to: Outline the latest treatment guidelines for prophylactic treatment of hereditary angioedema (HAE) and the rationale for why attenuated androgens are recommended second-line; Identify current therapies for first-line long-term prophylaxis of HAE; and Propose how to optimally manage the transition of patients with HAE from attenuated androgens to alternative prophylactic agents.